| |
| |
|
| Insider
Information: |
Newton Roger S |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
548,726 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,091,965 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
548,726 |
|
|
| Total
Value |
$1,091,965 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Esperion Therapeutics, Inc. |
ESPR |
Director |
2019-03-12 |
548,726 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2019-03-12 |
4 |
AS |
$50.06 |
$1,251,500 |
D/D |
(25,000) |
548,726 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-11-02 |
4 |
AS |
$50.76 |
$11,523 |
D/D |
(227) |
573,726 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-11-01 |
4 |
AS |
$50.01 |
$130,026 |
D/D |
(2,600) |
573,953 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-10-18 |
4 |
AS |
$50.00 |
$5,000 |
D/D |
(100) |
576,553 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-10-17 |
4 |
AS |
$50.02 |
$633,903 |
D/D |
(12,673) |
576,653 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-10-16 |
4 |
AS |
$50.01 |
$470,094 |
D/D |
(9,400) |
589,326 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-08-27 |
4 |
AS |
$50.65 |
$903,610 |
D/D |
(17,700) |
598,726 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-08-17 |
4 |
AS |
$50.06 |
$365,438 |
D/D |
(7,300) |
616,426 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-03-29 |
4 |
S |
$70.71 |
$1,146,713 |
D/D |
(15,956) |
623,726 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-03-29 |
4 |
AS |
$73.26 |
$662,563 |
D/D |
(9,044) |
639,682 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-02-07 |
4 |
D |
$6.99 |
$25,220 |
D/D |
(3,608) |
648,726 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2018-02-07 |
4 |
OE |
$6.99 |
$242,210 |
D/D |
34,651 |
652,334 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2017-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,000 |
617,683 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Executive Chairman, CSO |
• • – |
2013-07-01 |
4 |
B |
$14.00 |
$592,844 |
D/D |
42,346 |
629,683 |
2.81 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Executive Chairman, CSO |
• • – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
301,051 |
587,337 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Executive Chairman, CSOOfficer |
• • – |
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
286,286 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
